Litcius/Paper detail

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip Monk, Richard Marsden, Victoria Tear, J. Brookes, Toby N. Batten, M Mańkowski, Felicity Gabbay, Donna E. Davies, Stephen T. Holgate, Ling‐Pei Ho, Tristan Clark, Ratko Djukanović, Tom Wilkinson, Michael G. Crooks, Davinder Dosanjh, Salman Siddiqui, Najib M. Rahman, John A. Smith, Alex Horsley, Timothy Harrison, Dinesh Saralaya, Lorcan McGarvey, Alastair Watson, Edmund Foster, Adam Fleet, Dave Singh, Sophie Hemmings, Sandra Aitken, Sarah Dudley, Rona Beegan, Angela Thompson, Pedro MB Rodrigues

2020The Lancet Respiratory Medicine456 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakClinical trialBETA (programming language)Double blindInternal medicineVirologyPathologyOutbreakDiseaseAlternative medicineProgramming languageInfectious disease (medical specialty)Computer scienceDental Research and COVID-19COVID-19 Clinical Research StudiesInfection Control and Ventilation